GnRH |
LH/FSH |
Estrogen |
Primary defect |
Hypergonadotropic (POI) 佔40% |
High (FSH>20, LH>40 IU/L) |
Low |
Ovary (Turner’s disease, Swyer, 17a-reductase deficiency(男假性雌雄同體), 化療放療導致的卵巢衰竭) |
Eugonadotropic |
Normal (FSH, LH 5~20 IU/L) |
Normal |
Uterus, fallopian tube, obstruction or abnormality (Mullerian agenesis, PCOS, 厭食症, Asherman, Cervical stenosis, AIS, CAH, Hyperprolactinemia, Hyperthyroidism, hypothyroidism) |
Hypogonadotropic |
Low (FSH, LH<5 IU/L) |
Low |
Hypothalamus/pituitary (先天性分泌不良IHH, 厭食症, Sheehan syndrome, Kallmann syndrome) ***使用hMG治療Hypogonadotropic hypogonadism效果最好,約91.2%在6個cycle後可以排卵。 |
*** 備註:POI=Primary ovary insufficiency卵巢衰竭, CAH=Congenital adrenal hyperplasia(46, XX), AIS=Androgen insensitivity(46, XY)
*** hMG = Human Menopausal Gonadotropins (hMG, 人類停經期促性腺激素),是直接作用於濾泡的FSH。有腦下垂體或下視丘疾病的病人﹙譬如在腦下垂體壞死(Sheehan’s syndrome)或Kallman’s syndrome﹚HMG是誘導排卵的主要用藥。這些情況下,Clomid無法刺激下視丘及腦下垂體產生自體的FSH及LH,必須靠外加的HMG直接供應FSH及LH誘導排卵。另外在Clomid治療失敗,或引起黃體功能不良、子宮頸黏液明顯減少的病人,也可以改用HMG治療。
留言列表